Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Understanding Sociodemographic Barriers in Hematopoietic Stem Cell Transplantation Among Patients with Hematologic Malignancies: Insights from a North Carolina Cohort

Marie Michele Sainvil, Melissa Lowe, Delaney Underwood, Yan Li, Tomi F. Akinyemiju, Taewoong Choi, Cristina Gasparetto, Mitchell Horwitz, Gwynn D. Long, Richard Lopez, Stefanie Sarantopoulos, Edwin Alyea, III, Nelson J. Chao, Thomas W. LeBlanc, Yubin Kang, Sendhilnathan Ramalingam, Anthony D. Sung, Sanghee Hong

Blood (2024) 144 (Supplement 1): 2295.

https://doi.org/10.1182/blood-2024-211219

Published: 2024

Journal Articles

Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina

Blood (2024) 144 (Supplement 1): 5044.

https://doi.org/10.1182/blood-2024-211637

Published: 2024

Journal Articles

Hematopoietic Stem Cell Transplantation at Home

Anthony D. Sung, MD, Krista R. Nichols, RN, MSN, AOCNS, Julia A. Messina, MD, Kristi Romero, BA, Tara Dalton, MBS, Amy Bush, BA, Megan Covington, BS, Rebecca Shelby, PhD, Jennifer Frith, RN, MSN, OCN, Cristina J. Gasparetto, MD, Mitchell E. Horwitz, MD, Gwynn D. Long, MD, Richard Lopez, MD, David A. Rizzieri, MD, Stefanie Sarantopoulos, MD PhD, Keith M. Sullivan, MD, Nelson J. Chao, MDM.B.A

Blood (2017) 130 (Supplement 1): 745.

https://doi.org/10.1182/blood.V130.Suppl_1.745.745

Published: 2017

Journal Articles

Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning

Sarah Anand, MD, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, MD, Richard Lopez, MD, Gwynn D. Long, MD, Ashley K. Morris, PharmD, David A. Rizzieri, MD, Stefanie Sarantopoulos, MD PhD, Keith M Sullivan, MD, Anthony D. Sung, MD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2016) 128 (22): 3395.

https://doi.org/10.1182/blood.V128.22.3395.3395

Published: 2016

Journal Articles

Use of Dexamethasone Given to Sibling Donors as a Way of In Vivo Purging of Allo Reactive Donor T Cells in rhg-CSF Mobilized Peripheral Blood Stem Cell Transplantations Resulted in Significant Decrease in CD3+ Cells and Increased CD34+ Yield.

Khaleel K. Ashraf, MD, Arabella B. Tilden, PhD, Yufeng Li, PhD, Lawrence Lamb, PhD, Donna E. Salzman, MD, Matthew H. Carabasi, MD, Richard Lopez, MD, William P. Vaughan, MD

Blood (2007) 110 (11): 3047.

https://doi.org/10.1182/blood.V110.11.3047.3047

Published: 2007

Journal Articles

ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.

Khaleel K. Ashraf, MD, Arabella B. Tilden, PhD, Yufeng Li, PhD, Sameer Gupta, MD, Lawrence S. Lamb, PhD, Donna E. Salzman, MD, Richard Lopez, MD, William P. Vaughan, MD

Blood (2007) 110 (11): 5006.

https://doi.org/10.1182/blood.V110.11.5006.5006

Published: 2007

NARROW

Understanding Sociodemographic Barriers in Hematopoietic Stem Cell Transplantation Among Patients with Hematologic Malignancies: Insights from a North Carolina Cohort

Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina

Hematopoietic Stem Cell Transplantation at Home

Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning

Use of Dexamethasone Given to Sibling Donors as a Way of In Vivo Purging of Allo Reactive Donor T Cells in rhg-CSF Mobilized Peripheral Blood Stem Cell Transplantations Resulted in Significant Decrease in CD3+ Cells and Increased CD34+ Yield.

ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.

Email alerts

ASH Publications

American Society of Hematology

Understanding Sociodemographic Barriers in Hematopoietic Stem Cell Transplantation Among Patients with Hematologic Malignancies: Insights from a North Carolina Cohort

Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina

Hematopoietic Stem Cell Transplantation at Home

Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning

Use of Dexamethasone Given to Sibling Donors as a Way of In Vivo Purging of Allo Reactive Donor T Cells in rhg-CSF Mobilized Peripheral Blood Stem Cell Transplantations Resulted in Significant Decrease in CD3+ Cells and Increased CD34+ Yield.

ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only